Severity: Warning
Message: Undefined array key 1
Filename: helpers/my_audit_helper.php
Line Number: 6966
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 6966
Function: _error_handler
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3884
Function: getTopKeywords
File: /var/www/html/application/controllers/Detail.php
Line: 38
Function: pubMedSearch_Global
File: /var/www/html/index.php
Line: 316
Function: require_once
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00586-024-08592-0 | DOI Listing |
Alzheimers Dement
December 2024
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Introduction: The announcement of an Alzheimer's disease (AD) diagnosis is a complex process that requires careful consideration by healthcare professionals. This study aims to explore the desires of patients regarding the disclosure of their Alzheimer's diagnosis and to understand the practices adopted by physicians in this regard.
Methods: Within the context of memory disorders consultations, patients were queried about their preferences regarding the disclosure of an AD diagnosis if it were determined to be the cause of their memory issues.
BMC Public Health
January 2025
Department of Applied Health Sciences and Institute for Mental Health, University of Birmingham, Birmingham, UK.
Background: Following UK approval of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on 2/12/20 and 30/12/20 respectively, discussions about them emerged on the social media platform Twitter, (now 'X'). Previous research has shown that Twitter/ X is used by the UK public to engage with public health announcements and that social media influences public opinions of vaccines, including COVID-19 vaccines, globally. This study explored discussions on Twitter posted in response to the UK government's posts introducing the Pfizer-BioNTech and Oxford-AstraZeneca vaccines.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!